Why the study?
Does SQ 14225 reduce blood pressure in hypertensive patients refractory to traditional medical therapy?
Population
12 hypertensive patients refractory to traditional medical therapy
Design
Case_series
Follow-up
3 to 24 weeks
Authors
Loading...
Supports further study of oral ACE inhibition in refractory hypertension; should not yet change practice.
Does SQ 14225 reduce blood pressure in hypertensive patients refractory to traditional medical therapy?
SQ 14225 is an effective oral ACE inhibitor that significantly lowers blood pressure in patients refractory to traditional therapy.
Gavras et al. (1978) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: